مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

195
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Effect of Intravitreal Bevacizumab with Vitamin D Ssupplementation on Diabetic Macular Edema in Vitamin D Deficient Patients

Pages

  174-180

Keywords

Diabetes Mellitus (DM)Q1
Diabetic Macular Edema (DME)Q1

Abstract

 Purpose: To determine the effect of intravitreal injection of Bevacizumab (IVB), which is the standard treatment for diabetic macular edema, along with Vitamin D supplementation, on diabetic macular edema in patients with Vitamin D deficiency. Methods: Generally, 83 eyes of 83 patients with diabetes mellitus (DM) type 2 and diabetic macular edema (DME) were studied. The patients were divided into 3 groups: normal Vitamin D levels + IVB administration (Group 1, n=29), Vitamin D insufficient/deficient + IVB administration (Group 2, n=26), and Vitamin D insufficient/deficient + IVB administration+ oral Vitamin D supplementation (Group 3, n=28). All groups received 3 monthly IVB injections and group 3 received oral Vitamin D supplementation simultaneously. The patients were followed up 1, 3, and 6 months after the third baseline IVB with clinical examination, CDVA, and CMT measurements. Results: The mean baseline CDVA (LogMAR) in groups 1, 2, and 3 was 0. 68 ± 0. 16, 0. 72 ± 0. 14, and 0. 71 ± 0. 1, respectively. In months 1, 3, and 6, after the basic triple IVB injection, visual acuity improved in all groups, but the increase in visual acuity in month 6 was statistically significant in the group treated with Vitamin D supplement (group 3) and the group with normal Vitamin D levels (group 1) compared to the Vitamin D deficiency untreated group (group 2) (P<0. 001). Mean CMT decreased in all groups following IVB injections (466. 83 ± 57, 527. 46 ± 42. 3, and 500. 61 ± 56. 01 microns in groups 1, 2, and 3, respectively), but similar to visual acuity, only in month 6, these changes were significantly different in groups 1 and 3 compared to group 2 (P<0. 001). Conclusion: The correction of Vitamin D deficiency in DME patients with type 2 diabetes and Vitamin D deficiency, in addition to IVB injections, may play a role in improving CDVA and CMT.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    FEKRI, S., Roozdar, S., & SOHEILIAN, M.. (2020). Effect of Intravitreal Bevacizumab with Vitamin D Ssupplementation on Diabetic Macular Edema in Vitamin D Deficient Patients. BINA, 25(3 ), 174-180. SID. https://sid.ir/paper/415142/en

    Vancouver: Copy

    FEKRI S., Roozdar S., SOHEILIAN M.. Effect of Intravitreal Bevacizumab with Vitamin D Ssupplementation on Diabetic Macular Edema in Vitamin D Deficient Patients. BINA[Internet]. 2020;25(3 ):174-180. Available from: https://sid.ir/paper/415142/en

    IEEE: Copy

    S. FEKRI, S. Roozdar, and M. SOHEILIAN, “Effect of Intravitreal Bevacizumab with Vitamin D Ssupplementation on Diabetic Macular Edema in Vitamin D Deficient Patients,” BINA, vol. 25, no. 3 , pp. 174–180, 2020, [Online]. Available: https://sid.ir/paper/415142/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button